Trump drug-pricing speech adds dose of uncertainty for healthcare investors

NEW YORK (Reuters) – Investors are bracing for widespread volatility in healthcare stocks on Friday, when U.S. President Donald Trump is expected to give a highly anticipated speech about controlling prescription drug prices.